Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs.
Jacobo López-AbenteCristina Benito-VillalvillaXavier JaumontPascal PfisterPaolo TassinariOscar PalomaresPublished in: The European respiratory journal (2021)